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Summary
Insulin/IGF-1-like signaling (IIS) is central to growth and metabolism, and has a conserved role in
aging. In C. elegans, reductions in IIS increase stress resistance and longevity, effects that require
the IIS-inhibited FOXO protein DAF-16. The C. elegans transcription factor SKN-1 also defends
against oxidative stress, by mobilizing the conserved Phase 2 detoxification response. Here we show
that IIS not only opposes DAF-16, but also directly inhibits SKN-1 in parallel. The IIS kinases
AKT-1,-2 and SGK-1 phosphorylate SKN-1, and reduced IIS leads to constitutive SKN-1 nuclear
accumulation in the intestine and SKN-1 target gene activation. SKN-1 contributes to the increased
stress tolerance and longevity resulting from reduced IIS, and delays aging when expressed
transgenically. Furthermore, SKN-1 that is constitutively active increases lifespan independently of
DAF-16. Our findings indicate that the transcription network regulated by SKN-1 promotes
longevity, and is an important direct target of IIS.
Introduction
In many studies of aging, extended longevity correlates with enhanced resistance against
oxidative damage and other stresses (Finkel and Holbrook, 2000; Lithgow and Walker,
2002). In C. elegans, both lifespan and stress resistance can be increased by the alteration of
several processes, including Insulin/IGF-1-like signaling (IIS) (Friedman and Johnson, 1988;
Gottlieb and Ruvkun, 1994; Kenyon et al., 1993; Larsen, 1993), caloric intake (Houthoofd et
al., 2002), mitochondrial respiration (Dillin et al., 2002; Lakowski and Hekimi, 1996; Lee et
al., 2003), and germline function (Arantes-Oliveira et al., 2002). It is a formidable but critical
challenge to understand how modulation of these processes might inhibit or defend against
stresses that contribute to aging.
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Reductions in IIS have been associated with increased stress resistance and longevity in diverse
species (Kenyon, 2005). Studies in worms and flies have established the paradigm that these
effects derive from increased activity of the FOXO transcription factors, which are inhibited
through IIS-induced phosphorylation (Figure 1A) (Antebi, 2007; Kenyon, 2005). FOXO
proteins are also important in many of the biological effects of insulin in mammals (Accili and
Arden, 2004; van der Horst and Burgering, 2007). In C. elegans, signaling through the IIS
receptor DAF-2 ultimately directs the related kinases AKT-1, -2, and SGK-1 to phosphorylate
the FOXO protein DAF-16, thereby inhibiting its accumulation in nuclei (Henderson and
Johnson, 2001; Hertweck et al., 2004; Lin et al., 2001; Ogg et al., 1997). DAF-16 is required
for phenotypes that are associated with decreased IIS, including increases in stress resistance,
longevity, and the propensity to undergo diapause, the formation of long lived dauer larvae
that can survive adverse environmental conditions (Kenyon, 2005; Kenyon et al., 1993; Kimura
et al., 1997). DAF-16 regulates genes that represent diverse processes, including resistance to
oxidative and other stresses (Antebi, 2007; Kenyon, 2005).
The Phase 2 detoxification response also provides a conserved defense against oxidative stress,
and consists of numerous enzymes that scavenge free radicals and other reactive compounds,
and produce or transfer glutathione (McMahon et al., 2001). In C. elegans the Phase 2 response
is orchestrated by the transcription factor SKN-1. SKN-1 initiates development of the feeding
and digestive system during the earliest embryonic stages, then is required postembryonically
for normal lifespan and stress resistance (An and Blackwell, 2003; Bowerman et al., 1992).
SKN-1 is present in nuclei constitutively in the ASI neurons (putative hypothalamus) (An and
Blackwell, 2003), where it is required for longevity to be extended by dietary restriction (DR),
a condition that increases longevity in organisms as diverse as yeast and rodents (Bishop and
Guarente, 2007). The stress resistance function of SKN-1 is mediated by its expression in the
intestine (digestive system) (Bishop and Guarente, 2007), where SKN-1 accumulates in nuclei
and activates Phase 2 gene expression inducibly in response to stress (An and Blackwell,
2003). In the intestine, phosphorylation of SKN-1 by p38/Mitogen Activated Protein Kinase
(MAPK) signaling is required for its accumulation in nuclei, whilst negative regulation via
Glycogen Synthase Kinase-3 (GSK-3) phosphorylation is needed to prevent this from
occurring constitutively (Figure 1A) (An et al., 2005; Inoue et al., 2005).
As daf-16 is required for the increased stress resistance and longevity that are seen when IIS
is reduced, it has seemed likely that these effects of decreased IIS could be accounted for by
increased DAF-16 activity. However, we reasoned that if it is advantageous for IIS to inhibit
stress response genes by acting on DAF-16, then IIS might also oppose SKN-1 (Figure 1A).
Accordingly, here we show that reductions in IIS cause SKN-1 to accumulate constitutively
in intestinal nuclei in the absence of stress, and to activate Phase 2 target genes. Importantly,
these events do not require daf-16. AKT-1, -2 and SGK-1 phosphorylate SKN-1 at multiple
sites, and mutation of an AKT phosphorylation site results in SKN-1 being present in intestinal
nuclei constitutively. skn-1 mutations significantly suppress the oxidative stress resistance and
longevity phenotypes associated with reduced IIS. Aging is delayed when SKN-1 is expressed
transgenically, and a mutant SKN-1 form that localizes constitutively to intestinal nuclei
increases lifespan in the absence of daf-16. In summary, our data indicate that IIS directly
inhibits SKN-1 in parallel to DAF-16, that SKN-1 contributes to the stress and longevity
phenotypes associated with reduced IIS, and that SKN-1 defines an important pro-longevity
mechanism.
Results
DAF-2 signaling inhibits SKN-1 accumulation in intestinal nuclei
If IIS inhibits SKN-1 analogously to DAF-16 (Figure 1A), then reduced DAF-2 signaling
should allow SKN-1 to accumulate in intestinal nuclei. To test this idea, we first investigated
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how reductions in DAF-2 activity affect the distribution of SKN-1 that is expressed from the
previously described SKN-1B/C::GFP transgene, (Figure 1B). This transgene rescues the
maternal lethality, stress sensitivity, and DR-associated longevity defects of skn-1 mutants
(An and Blackwell, 2003; An et al., 2005; Bishop and Guarente, 2007). SKN-1B/C::GFP
encodes two of three SKN-1 isoforms, SKN-1C and SKN-1B, which are expressed in the
intestine and ASI neurons, respectively (Bishop and Guarente, 2007). In wild type (WT)
animals that carry extrachromosomal or integrated SKN-1B/C::GFP, SKN-1::GFP is generally
undetectable in intestinal nuclei except under stress conditions, or after inhibition of its
phosphorylation by GSK-3 (An and Blackwell, 2003; An, et al., 2005). In contrast,
SKN-1::GFP was constitutively present in intestinal nuclei of transgenic daf-2(e1370) and
daf-2(e1368) animals, or in WT transgenics exposed to daf-2 RNA interference (RNAi) at
either 20°C, or low temperature (16°C) Figure 1C and 1E; see also Figures S1A, S1B and S1C
in the Supplemental Data available with this article online). This nuclear SKN-1 appeared to
correspond to SKN- 1C, because RNAi against this isoform prevented SKN-1::GFP from
accumulating in intestinal nuclei in response to daf-2 mutation (Figure 1D).
We also analyzed a transgene that encodes all three SKN-1 isoforms in the context of a large
operon (SKN-1op::GFP; Figure 1B). In the WT background this transgene was expressed in
a similar pattern to SKN-1B/C::GFP (not shown), and in daf-2(e1370) SKN-1 that was
expressed from SKN-1op::GFP also accumulated in intestinal nuclei constitutively (Figure
1E). In contrast to these effects in the intestine, daf-2 mutation did not obviously alter the levels
of nuclear SKN-1::GFP in the ASI neurons (Figure 1C and 1D; data not shown). We conclude
that signaling through DAF-2 may be required to prevent SKN-1 from accumulating
constitutively in intestinal nuclei.
DAF-2 signaling inhibits SKN-1 directly, through phosphorylation
Signaling through DAF-2 ultimately activates the AKT-1, -2 and SGK-1 kinases, which
phosphorylate and inhibit DAF-16 (Figure 1A) (Cahill et al., 2001; Hertweck et al., 2004; Lin
et al., 2001). RNAi knockdown of akt-1;akt-2 or sgk-1 dramatically increased the presence in
intestinal nuclei of SKN-1::GFP that was expressed from either SKN- 1B/C::GFP or
SKN-1op::GFP (Figure 2A and 2B), supporting the model that IIS inhibits SKN-1 directly.
Importantly, daf-16 was not required for SKN-1 expression, or for the nuclear accumulation
of SKN-1 that resulted from reductions in IIS. A constitutively nuclear SKN-1 substitution
mutant in which a critical inhibitory GSK-3 phosphorylation site has been altered (SKN-1
(S393A); An, et al., (2005)), was appropriately present in intestinal nuclei in null daf-16
animals (Figure S2). In addition, in a null daf-16 background, RNAi of the IIS kinases still
increased the levels of intestinal nuclear SKN- 1::GFP expressed from SKN-1op::GFP (Figure
2A). Finally, in daf-2(e1370) animals, the nuclear accumulation of SKN-1 expressed from
SKN-1B/C::GFP was not reduced by daf-16 RNAi (Figure S1D). We conclude that the IIS
pathway inhibits SKN-1 in the intestine, and that this regulation occurs independently of
DAF-16.
We previously observed that p38 MAPK signaling is required for SKN-1 to accumulate in
intestinal nuclei not only in response to stress, but also when GSK-3 phosphorylation of SKN-1
is inhibited under normal conditions (An et al., 2005; Inoue et al., 2005). In the latter case,
even though negative regulation of SKN-1 is impaired, the low-level background p38 signaling
that is seen under normal conditions is still required. To test whether p38 signaling is also
needed for SKN-1 to be present in intestinal nuclei when IIS is reduced, we performed
akt-1;akt-2 and sgk-1 RNAi in animals that lack the p38 pathway MAPK kinase SEK-1 (Inoue
et al., 2005). In sek-1(km4) mutants, SKN-1::GFP failed to accumulate in intestinal nuclei in
response to IIS kinase RNAi (Figure 2B). Similarly, RNAi of the IIS kinases did not allow
nuclear accumulation of a SKN-1 mutant in which two key p38 phosphorylation sites had been
Tullet et al. Page 3
Cell. Author manuscript; available in PMC 2009 March 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
altered (Figure S3). We conclude that the SKN-1 nuclear accumulation that is allowed when
IIS is reduced is appropriately dependent upon p38 MAPK signaling.
We next investigated whether SKN-1 is phosphorylated by the downstream IIS kinases
AKT-1,-2 and SGK-1. Analysis using SCANSITE identified 7 potential AKT phosphorylation
motifs within SKN-1C (Table S1). Four additional potential AKT phosphorylation motifs were
detected within the unique N-terminal 90 amino acids of SKN-1A (SKN-1A(1–90); Table S1),
which is predicted by expressed sequence tag analysis to be the most abundant SKN-1 isoform
(www.wormbase.org). AKT-1::GFP, AKT-2::GFP and SGK-1::GFP that were purified from
WT C. elegans (Hertweck et al., 2004) each phosphorylated full-length SKN-1C in vitro at
least as robustly as they phosphorylated DAF-16 (Figure 2C). In contrast, SKN-1A(1–90) was
phosphorylated by AKT-1 and AKT-2, but not SGK-1 (Figure 2D), consistent with the previous
finding that AKT-1,-2 and SGK-1 differ with respect to their phosphorylation sites within the
mammalian DAF-16 homolog FOXO3a (Brunet et al., 2001). Significantly, SKN-1 was not
phosphorylated robustly by these same kinases if they were purified from daf- 2(e1370) animals
(Figure 2C and 2D). We conclude that SKN-1 is a direct substrate of the downstream IIS
kinases, and that their phosphorylation of SKN-1 depends upon signaling through DAF-2.
We then performed a partial mapping of IIS kinase phosphorylation sites in SKN-1. Within
SKN-1A(1–90), Ala substitution at the strongly predicted AKT site Ser-12 reduced its
phosphorylation by AKT-2 dramatically (Figure 2D) identifying Ser-12 as an AKT-2 site.
AKT-1 phosphorylation was only slightly reduced by this mutation, but was substantially
decreased by concurrent substitution of Ser-12 and each of three other sites within this region
(Figure 2E). AKT and SGK also preferentially phosphorylated different regions or individual
sites within the remainder of SKN-1, which corresponds to the SKN-1C isoform (Figure 2F
and 2G; Table S1). Together, our data show that AKT- 1, -2 and SGK-1 phosphorylate SKN-1
at multiple overlapping and distinct sites.
To investigate whether SKN-1 is regulated directly by IIS kinase phosphorylation in vivo, we
substituted Ala at its most strongly predicted AKT site (Ser-12 of SKN-1A) (Table S1), within
the SKN-1op::GFP transgene. In each transgenic line examined, this substitution resulted in
dramatic constitutive intestinal nuclear accumulation of SKN-1A (Figure 2H and 2I). This
finding shows that SKN-1A is expressed in the intestine, and that the AKT phosphorylation
site Ser-12 is essential for its appropriate regulation. This strongly supports the model that
signaling through the DAF-2 pathway directly inhibits SKN-1 in vivo.
Inhibition of SKN-1 target genes by IIS
Given that IIS directly inhibits the SKN-1 protein in the intestine, it follows that IIS should
also reduce expression of SKN-1 target genes. To test this idea, we first asked how reductions
in IIS affect expression of two SKN-1 target reporter transgenes (Figure 3A and 3B). In the
intestine, SKN-1 directly induces expression of gcs-1 (γ-glutamyl cysteine synthetase), which
encodes an enzyme rate-limiting for glutathione biosynthesis (Figure 3A) (An and Blackwell,
2003). In the intestine a gcs-1::GFP transcriptional reporter is generally expressed at very low
levels in the absence of stress, but was up-regulated by akt-1;akt-2 or sgk-1 RNAi (Figure 3C).
This induction was abolished by mutation of an important SKN-1 binding site (gcs-1Δ2mut3;
Figure 3A), but not by absence of daf-16 (Figure 3C), indicating that SKN-1 but not DAF-16
was required for IIS kinase RNAi to activate the gcs-1 promoter. Interestingly, gcs-1 was not
induced by daf-2 RNAi, implying that its regulation by AKT and SGK-1 might involve an
additional input (data not shown). In contrast, a translational fusion reporter for the SKN-1
target gene gst-7 (Glutathione S-Transferase; Figure S5) was comparably induced in the
intestine by either daf-2 or IIS kinase RNAi (Figures 3B and 3D).
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We next used quantitative (Q)-PCR to analyze how daf-2 mutation affected the levels of mRNA
expressed from a set of known or predicted SKN-1 target Phase 2 genes (An and Blackwell,
2003; Kell et al., 2007). As would be expected, SKN-1 was not required for daf-2 mutation to
induce expression of a negative control for our experiments, the DAF-16 target sod-3 (Figure
3E) (Antebi, 2007). The levels of gcs-1 mRNA were largely unaffected in this daf-2 mutant
(Figure 3F), in agreement with our reporter data and the high levels of skn-1-independent
gcs-1 expression seen in the pharynx (An and Blackwell, 2003). In contrast, four different
gst genes were strongly upregulated by daf-2 mutation in a manner that was substantially or
completely dependent upon skn-1. (Figure 3G–J). DAF-16 contributed to induction of some
of these genes, but the SKN-1 target gst-10 was upregulated by daf-2 mutation independently
of daf-16 (Figure 3G–J). Together, our results indicate that when DAF-2 pathway signaling is
reduced, SKN-1 induces a gene expression program that overlaps only partially with that of
DAF-16.
skn-1 contributes to the increased longevity and stress resistance associated with reduced
IIS
Having established that DAF-2 and IIS inhibit SKN-1 directly, and thereby suppress SKN-1-
dependent gene expression, we next asked whether SKN-1 contributes to phenotypes that are
associated with decreased IIS. We engineered daf-2;skn-1 double mutants that each carried
one of three skn-1 mutations, along with one of two daf-2 alleles. Each skn-1 mutation (Figure
1B) results in reduced stress resistance and longevity (Figure 4; Table 1) (An and Blackwell,
2003), failure of DR to extend lifespan (Bishop and Guarente, 2007), and maternally-derived
embryonic lethality (Bowerman et al., 1992). The Class 2 daf-2 mutant e1370 is stress-resistant
and lives much longer than WT at 20°C (Figure 4A and 4C), but this increased lifespan is
accompanied by various dauer-like abnormalities (Gems et al., 1998; Kimura et al., 1997). The
Class 1 daf-2 mutation e1368 increases lifespan to a lesser extent (Figure 4D), but these animals
appear essentially normal. We also tested how skn-1 mutations affect similar phenotypes
caused by RNAi of the IIS downstream kinases. At 25°C, sgk-1 RNAi increases both oxidative
stress resistance and lifespan, dependent upon daf-16 (Hertweck et al., 2004). Previously,
lifespan was not extended when akt-1 RNAi was performed in the akt-2(ok393) mutant
(Hertweck et al., 2004), but we have now observed that akt-1;akt-2 RNAi significantly
increases stress resistance and lifespan in an RNAi hypersensitive strain (Figure 4B and 4F;
Table 1). This suggests that AKT-1,-2 and SGK-1 may contribute comparably to the effects
of DAF-2 signaling on stress resistance and longevity.
Initially, we tested whether the IIS-associated phenotypes of dauer formation and elevated
stress resistance require skn-1. skn-1 RNAi did not prevent the constitutive dauer entry
associated with the daf-2(e1370) mutation, or akt-1;akt-2 RNAi (supplemental data). In
contrast, and consistent with its role in Phase 2 detoxification, mutations in skn-1 dramatically
suppressed the increases in oxidative stress resistance seen in each of these contexts of reduced
IIS (Figure 4A and 4B).
We then investigated how skn-1 contributes to the increased longevity deriving from decreased
daf-2 function. Only skn-1(zu129) suppressed the increased longevity of the Class 2 daf-2 allele
e1370 (Figure 4C; Table 1). In contrast, all three skn-1 mutations significantly reduced the
lifespan of the Class 1 daf-2 mutant e1368 (Figure 4D; Table 1). These skn-1 mutations also
altered the shape of the daf-2(e1368) survival plot, so that the longest-living double mutant
animals appeared to be less dependent upon skn-1 than the remaining population (Figure 4D).
Accordingly, when we excluded the 20% most long-lived animals from statistical analysis,
two of three skn-1 mutations affected death rate more severely in daf-2(e1368) animals than
WT (Figure S7; Tables S3 and S4). Importantly, an RNAi-sensitive genetic background
skn-1 RNAi decreased the lifespan of daf-2(e1368) but not control animals (Figure 4E; Table
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1 and Table S4), indicating that this daf-2 mutant is more susceptible than WT to a reduction
in SKN-1 levels. daf-2(e1368) lifespan was similarly decreased by either skn-1 or skn-1a/c
RNAi (Figure 4E; Table 1 and Table S4), indicating that the SKN-1 A and/or C isoforms are
required for the longevity associated with daf-2(e1368). daf-2(e1368) lifespan was also
decreased by feeding of skn-1 RNAi from the beginning of adulthood (Figure S8), indicating
an effect on aging, not development.
Mutations in skn-1 also suppressed the lifespan extensions associated with reductions in IIS
kinase levels. Each of two skn-1 alleles that we analyzed (zu67 and zu 129) completely
eliminated the dramatic increase in lifespan deriving from sgk-1 RNAi (Figure 4G; Table 1
and Table S4). In addition, two of three skn-1 alleles significantly reduced the lifespan of
akt-1;akt-2 RNAi animals (Figure 4F; Table 1). We conclude that SKN-1 makes important
contributions to the increases in stress resistance and longevity that are associated with
reductions in IIS activity.
We next asked whether skn-1 mutations might cause a general sickness that limits lifespan, by
investigating whether skn-1 affects the long lifespan of animals with reduced mitochondrial
electron transport chain activity (Dillin et al., 2002; Lee et al., 2003; Rea et al., 2007). In
agreement with a recent report (Rea et al., 2007), a skn-1 mutation did not reduce the large
increases in lifespan associated with RNAi against either cytochrome c reductase (cyc-1) or
cytochrome c oxidase (cco-1) (Figure 4H and S9; Table 1). This indicates that while skn-1 is
important for lifespan in long-lived animals in which IIS is reduced, lack of skn-1 does not
limit longevity non-specifically.
SKN-1 promotes longevity
The involvement of skn-1 in the longevity effects of IIS led us to investigate whether SKN-1
has an independent pro-longevity function. Previously, lifespan was modestly increased by
transgenic overexpression of either WT or constitutively nuclear forms of DAF-16 (Henderson
and Johnson, 2001; Lin et al., 2001). To investigate whether modulation of SKN-1 expression
can extend lifespan, we first analyzed otherwise WT strains in which either the SKN-1B/
C::GFP or SKN-1B/C S393A::GFP transgenes were present. The SKN-1B/C S393A::GFP
transgene, which expresses constitutively nuclear SKN-1 in the intestine, increased mean
lifespan variably but consistently (by 5%–21%; Figure 5A; Table 2). A modest increase was
also seen with SKN-1B/C::GFP (Ex001; Figure 5B; Table 2).
Interestingly, we had previously observed that skn-1 transgenes not only rescue the oxidative
stress sensitivity of skn-1(zu67) mutants, but also increase their stress resistance to well beyond
that of WT (An et al., 2005). Similarly, strains in which skn-1(zu67) was rescued with these
transgenes also lived longer than wild type animals that carried the same transgene arrays
(arrays Ex001 and Ex008, Figures 5A and 5B; Table 2). This difference was corroborated in
independent strains that were generated by breeding the Ex001[SKN-1B/C::GFP] array from
the WT into skn-1(zu67) and skn-1(zu129) (Figures S10A, S10B, and S11), and in an additional
skn-1(zu67) strain carrying SKN-1B/C S393A::GFP (Ex020, Figure 5B; Table 2). Perhaps an
optimal window of SKN-1 expression is important for longevity, because we found that
expression of SKN-1 from high-copy arrays can be toxic (data not shown). Significantly,
rescued skn-1(zu67) Ex001[SKN-1B/C::GFP] animals maintained the ability to move longer
than WT (Figure S10C), indicating that transgenic skn-1 expression delayed the aging process.
RNAi that was targeted to transgenic SKN-1C (skn-1a/c RNAi, Figure 1B) eliminated
expression of intestinal nuclear SKN-1 from SKN-1B/C S393A::GFP (Figure S12), and
suppressed the extended lifespan of a transgenically rescued skn-1(zu67) strain (Figure 5C).
Taken together, our results indicate that SKN-1 promotes longevity, an effect that appears to
require the SKN-1C isoform.
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We next investigated whether daf-16 is required for transgenic SKN-1 to increase lifespan,
because of the general importance of daf-16 for C. elegans longevity, and because SKN-1 and
DAF-16 overlap in regulating some target genes (Figure 3E–J). When we bred a SKN-1 S393A
transgenic array (Ex008) into the null mutant daf-16(mgDf47), lifespan was modestly but
significantly increased in 2 of 3 experiments (Figure 5D; Table 2 and Table S6). Similarly,
after daf-16 RNAi the lifespan of skn-1(zu67) animals was reduced, but presence of an array
that expresses constitutively nuclear SKN- 1(S393A) (Ex008 or 020) still increased skn-1
(zu67) lifespan to beyond that of WT (Figure 5E; Table 2). Interestingly, daf-16 RNAi
completely suppressed the lifespan extension associated with transgenic WT SKN-1 (Figure
S13; Table 2), suggesting that reductions in DAF-16 levels not only reduce lifespan, but also
might free up negative regulatory mechanisms that act on SKN-1. Taken together, our data
suggest that SKN-1 can promote longevity independently of DAF-16, provided that SKN-1 is
released from negative regulation in the intestine.
Discussion
It is well established that FOXO proteins are inhibited directly by the IIS pathway, and that
the FOXO protein DAF-16 is required for the increased longevity and stress resistance that
result from decreased IIS in C. elegans (Kenyon, 2005). This has made it difficult to imagine
that another transcription factor might be regulated similarly by IIS in parallel to FOXO, and
could play a major role in IIS-regulated processes. However, here we have identified SKN-1
as the second transcription factor that is known to be inhibited directly by IIS. We have also
shown that IIS inhibits SKN-1 target genes, and that SKN-1 contributes to the stress resistance
and longevity phenotypes of reduced IIS, and functions as a pro-longevity factor.
Direct regulation of SKN-1 by IIS
Multiple lines of evidence indicate that IIS inhibits SKN-1 in the intestine directly (Figure 1A).
Reductions in IIS activity resulted in SKN-1A and SKN-1C being present in intestinal nuclei
in the absence of either stress or DAF-16, and in induction of SKN-1 target genes (Figure 1E,
Figures 2A, 2B, and Figure 3). SKN-1 isoforms were phosphorylated by AKT-1,-2 and SGK-1
at multiple sites, and mutation of an AKT site (Ser-12) led to SKN-1A being present in intestinal
nuclei constitutively (Figure 2H and 2I). The AKT and SGK kinases differed in their
preferences for sites within SKN-1, consistent with previous analyses of their phosphorylation
of FOXO (Brunet et al., 2001). The complexity of this regulation could potentially allow SKN-1
to integrate inputs from multiple signals or molecular interactions.
We also observed that SKN-1 contributes significantly to some IIS associated phenotypes.
skn-1 mutations dramatically suppressed the increases in stress resistance deriving from
sgk-1 RNAi, akt-1;akt-2 RNAi, and the daf-2(e1370) mutation (Figure 4A and 4B). Lack of
skn-1 completely suppressed the increased lifespan deriving from sgk-1 RNAi, reduced the
extended longevity of akt-1;akt-2 RNAi animals (Figures 4F and 4G) and suppressed the
increased lifespan of the Class 1 daf-2 allele e1368 (Figure 4D). Importantly, skn-1 RNAi
reduced the lifespan of daf-2(e1368) but not WT animals (Figure 4E), indicating that daf-2
(e1368) was more severely affected than WT by partial loss of skn-1 function. In contrast,
skn-1 mutation did not suppress the long life associated with RNAi of mitochondrial respiratory
chain components (Figure 4H and Figure S9), indicating that lack of skn-1 does not reduce
lifespan non-specifically. Interestingly, skn-1 mutations also did not consistently suppress the
lifespan extension of daf-2(e1370) mutants (Figure 4C). However, dauer-like phenotypes are
associated with this Class 2 allele (Gems et al., 1998), suggesting that this difference might
reflect the apparent dispensability of SKN-1 for dauer formation (Supplementary data).
The simplest model to explain the contributions of SKN-1 to IIS-associated longevity is that
they derive from Phase 2 detoxification gene expression in the intestine. Our finding that
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skn-1a/c RNAi suppresses daf-2(e1368) longevity (Figure 4E) is consistent with this idea,
although we cannot exclude that other tissues or SKN-1 functions are involved. We conclude
that daf-16 is necessary but not sufficient to confer the increases in stress resistance and
longevity that are associated with reduced IIS, and that these increases also involve skn-1.
In contrast to the regulation of SKN-1 by IIS in the intestine, daf-2 mutation did not obviously
affect SKN-1 levels in the ASI neurons (Figure 1C; not shown), in which SKN-1B is required
for DR to extend lifespan (Bishop and Guarente, 2007). However, we cannot exclude that IIS
might subtly influence the levels or activity of endogenous SKN-1 in ASI. This possibility
could help resolve the apparent paradox that in C. elegans most DR protocols extend lifespan
independently of daf-16, and therefore seemingly without input from IIS (Antebi, 2007; Bishop
and Guarente, 2007; Greer et al., 2007; Houthoofd et al., 2003; Kenyon, 2005; Panowski et
al., 2007).
SKN-1 is the sequence and functional counterpart to the mammalian NF-E2-related factor (Nrf)
proteins (An and Blackwell, 2003), which orchestrate the Phase 2 detoxification response
(Hayes and McMahon, 2001). Our results predict that the conserved IIS pathway might also
regulate mammalian Nrf proteins, which include potential AKT sites (Table S1). Why would
it be advantageous for IIS to decrease stress resistance? Many signaling cascades are influenced
by redox status (Tonks, 2005). In particular, IIS is attenuated by Protein Tyrosine Phosphatase
(PTP)1B, which is inhibited by reactive oxygen species (ROS) via the oxidation of conserved
cysteine residues (Goldstein et al., 2005; Tonks, 2005). Thus, by inhibiting DAF-16/FOXO
and SKN-1/Nrf, IIS could suppress antioxidant defenses that would lead to a reducing
environment, and that in turn might decrease IIS effectiveness. This is consistent with evidence
that insulin induces starved cells to produce a ‘burst’ of ROS, and that IIS functions more
effectively under oxidative conditions (Goldstein et al., 2005).
Pro-longevity functions of SKN-1
Our finding that transgenic SKN-1 expression extends lifespan (Figures 5A and 5B)
demonstrates that skn-1 has an independent pro-longevity function. This activity appears to
require the action of the intestinal SKN-1C isoform, because it is suppressed by skn-1a/c RNAi
(Figure 5C). This pro-longevity activity of SKN-1 thus appears to be distinct from its ASI-
mediated role in DR-induced longevity (Bishop and Guarente, 2007). The observation that
transgenic SKN-1 increased lifespan more robustly in skn-1 mutants than in the WT (Figures
5A and 5B) suggests that the systemic effects of SKN-1 expression may be complex. However,
taken together, our data demonstrate that SKN-1 levels can be adjusted to extend lifespan and
delay aging. We propose that the ancestral function of SKN-1 in Phase 2 detoxification can be
modulated by either reductions in IIS or adjustment of SKN-1 expression to extend lifespan,
raising the exciting possibility that this detoxification system might be of general and conserved
importance for longevity.
In the context of reduced IIS, SKN-1 and DAF-16 appeared to have both distinct and
overlapping functions (Figure 3). daf-16 contributed to expression of some skn-1-dependent
Phase 2 detoxification genes (Figure 3E–I), but other SKN-1 targets were daf-16-independent
(Figure 3J), consistent with our finding that transgenic expression of SKN-1 S393A increased
longevity independently of daf-16 (Figure 5D and 5E). Our data indicate that SKN-1 has
important activities that are largely independent of DAF-16, making it of intense interest to
dissect the extent to which these two transcription factors cooperate or act independently under
normal, stress, and reduced IIS conditions. It is interesting that transgenic overexpression of
neither DAF-16 or SKN-1 recapitulates the dramatic increases in longevity seen with
reductions in DAF-2 function ((Lin et al., 2001); Figure 5). One possibility is that simultaneous
overexpression of both transcription factors is necessary, although modifications of these
proteins or other signals associated with decreased IIS might also be required. Our intriguing
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observation that daf-16 RNAi suppressed lifespan extension by the WT SKN-1B/C::GFP
transgene (Figure S13) suggests that DAF-16 may influence processes that regulate SKN-1.
This could involve DAF-16 regulating genes that affect SKN-1, but a simpler model is that
SKN-1 and DAF-16 compete for binding to negative regulators that include AKT-1, -2 and
SGK-1 (Figure 1A). Thus, decreasing DAF-16 levels would increase the ratio of negative
regulators available to sequester SKN-1 in the cytoplasm.
Our results add SKN-1 to the small group of C. elegans transcription regulators that extend
longevity when expressed transgenically (Figure 5F). SIR-2.1, PHA-4, DAF-16, and SKN-1
or their orthologs have all been shown to influence aspects of metabolism, and thereby
presumably may affect the rates of damage that leads to aging (Accili and Arden, 2004; Bishop
and Guarente, 2007; Kenyon, 2005; Panowski et al., 2007; van der Horst and Burgering,
2007). Importantly, SKN-1, HSF-1, and each of these other proteins has also been implicated
in resistance to free radical or other stresses (Figure 5F; see text), supporting the idea that stress
defenses and detoxification are fundamentally important for longevity. A remarkable web of
functional interactions among these factors has been uncovered, including our demonstration
here that DAF-16 and SKN-1 are regulated in parallel by IIS (Figure 5F). These interactions
could be important for coordinating how these proteins respond in different tissues to various
scenarios of nutrient availability and stress. As these regulators are also evolutionarily
conserved, it seems likely that a deeper understanding of interactions among them will be
broadly relevant to elucidating how these proteins influence metabolism, stress resistance, and
possibly longevity across species.
Experimental procedures
All supplemental data and experimental procedures, including details of cloning, strains, RNAi,
GFP scoring system, and assays for lifespan, movement, and reproduction are available online.
In vitro kinase assay
Kinases were isolated from sonicated worm lysates of N2 Ex[AKT-1::GFP], N2 Ex
[AKT-2::GFP] and N2 Ex[AKT-1::GFP] (Hertweck et al., 2004), using a GFP antibody bound
to protein A/G agarose beads. These purified kinases were used to phosphorylate 6µg of
bacterially expressed GST-SKN-1 fusion proteins in the presence of 6 µCi [γP32]ATP. After
phosphorylation, samples were washed in 50 mM Tris/HCl (pH 8.0), 100 mM NaCl, 10%
glycerol, and 1% Triton X-100, and analyzed by SDS-PAGE and autoradiography.
RNAi
Feeding RNAi was carried out as previously described, with empty pL4440 as the control
((Kamath et al., 2001); supplementary methods). To avoid maternal lethality in experiments
using skn-1 or skn-1a/c RNAi, animals were hatched on HT115 bacteria expressing control
RNAi, and were transferred to skn-1 RNAi at the L1 stage or on the first day of adulthood. For
lifespan experiments that required feeding of other RNAi, animals were exposed to bacteria
expressing the appropriate construct continually starting from hatching.
Lifespan analysis
Prior to experiments, all animals were maintained at the permissive temperature and grown for
at least two generations in the presence of food to assure health. Lifespan assays were
performed essentially as described (Hsin and Kenyon, 1999)(Supplementary methods).
Survival plots, p values (Log-Rank) and proportional hazards were determined using JMP
software, version 5.1.
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Oxidative stress resistance assay
To assess stress resistance, young adults were transferred to plates that contained 7.5 mM t-
butyl hydrogen peroxide (Sigma) or 150 mM paraquat (Sigma) in nematode growth media.
These plates had been seeded with OP50 or HT115 expressing the appropriate dsRNAs.
Animals were incubated on these plates at 20°C, and periodically scored for survival.
RNA isolation and quantitative PCR
Animals were picked to clean plates to minimize contamination, then total RNA was extracted
from approximately 200 animals suspended in 50µl M9. RNA was extracted using Trizol
(Sigma) and cDNA was synthesized using the Invitrogen SuperscriptTM Reverse Transcriptase
Kit. SYBR Green Real Time PCR was carried out using the ABI 7700 and normalized to
act-1. Primer sequences are available on request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Accumulation of SKN-1 in intestinal nuclei is inhibited by DAF-2
A) A partial schematic of C. elegans insulin-like signaling and our working model. B) skn-1
isoforms, alleles, and transgenes. The SKN-1A isoform is transcribed from an upstream operon
promoter, and differs from SKN-1C by the addition of 90 amino acids at its N-terminus.
SKN-1B and SKN-1C are each expressed from their own distinct upstream promoter (An and
Blackwell, 2003; Bishop and Guarente, 2007). The skn-1(zu67), (zu129), and (zu135)
mutations each create a premature stop codon (B. Bowerman, personal communication). Green
Fluorescent Protein (GFP) is fused to the C-terminus of SKN-1 in the transgenes indicated at
the bottom. Strains that carry these and other transgenes are described in Table S2. The skn-1a/
c RNAi construct includes only coding sequence, and targets both SKN-1A and SKN-1C, but
does not alter the levels of SKN-1B in the ASI neurons (Bishop and Guarente, 2007). C)
SKN-1::GFP accumulates in intestinal nuclei when DAF-2 activity is reduced. D) Intestinal
expression of SKN-1B/C::GFP in daf-2(e1370) derives from SKN-1C. E) Quantification of
SKN-1 intestinal nuclear accumulation. Here and in Figure 2, results of experiments performed
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on L4 larvae have been combined and scored as described in the supplementary methods and
in (An and Blackwell, 2003; An et al., 2005). p values were derived from a chi2 test.
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Figure 2. DAF-2 signaling inhibits nuclear accumulation of SKN-1 directly, and independently of
DAF-16
A) akt-1;akt-2 or sgk-1 RNAi allows daf-16-independent accumulation of SKN-1 in intestinal
nuclei. Expression of SKN-1op::GFP was monitored. akt-1 or akt-2 RNAi had a similar effect
to combined akt-1;akt-2 RNAi (data not shown). B) RNAi depletion of the downstream IIS
kinases causes sek-1-dependent accumulation of SKN-1 in intestinal nuclei. Expression of
SKN-1B/C::GFP was monitored. C) SKN-1C is phosphorylated by AKT-1, AKT-2, and
SGK-1 comparably to DAF-16, dependent upon daf-2. Here and in panels (D–G),
AKT-1::GFP, AKT-2::GFP and SGK-1::GFP were immunoprecipitated from WT or daf-2
(e1370) C. elegans lysates with anti-GFP antibody, quantitated by Western blotting with anti-
GFP, and used to phosphorylate purified GST-fused SKN-1 or DAF-16 proteins with [γP32]
ATP. GST controls are shown in Figure S4B. These kinases appropriately required activation
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in C. elegans, as they did not phosphorylate SKN-1 after they had been expressed in E. coli
(Figure S4A). D) The unique 90aa region at the SKN-A N-terminus (SKN-1A(1–90)) is
phosphorylated by the AKT kinases but not SGK-1, dependent upon daf-2. E) Partial mapping
of AKT-1 sites within SKN-1A(1–90). F) AKT and SGK phosphorylate particular regions of
SKN-1C. Here and in panel (G), residues are numbered as in SKN-1A, so that the first residue
of SKN-1C is numbered as 91. G) Partial mapping of AKT-1, AKT-2, and SGK-1 sites within
SKN-1C fragments. H and I) Substitution of a strongly predicted AKT site within SKN-1A
(1–90), Ser-12 (Table S1), results in nuclear accumulation of SKN-1A::GFP. In some lines
low levels of SKN-1::GFP were observed in additional head neurons, hypodermis, and other
tissues, particularly if Ser-12 was mutated (data not shown).
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Figure 3. SKN-1 target genes downstream of IIS
A and B) Schematics of the gcs-1 promoter (An and Blackwell, 2003), and the GST-
7::GFP translational fusion. Triangles mark SKN-1 binding sites. gcs-1Δ2::GFP lacks a
promoter region required for SKN-1-independent pharyngeal expression, and gcs-1
Δ2mut3::GFP lacks a SKN-1 binding site that is important for skn-1-dependent gcs-1
expression in the intestine and ASI neurons (An and Blackwell, 2003). C) gcs-1::GFP is
induced in the intestine independently of daf-16 in response to akt-1;akt-2 and sgk-1 RNAi.
Here and in (D), results of multiple experiments performed on L4 larvae have been combined
and scored as described in the supplementary methods and (An and Blackwell, 2003; An et al.,
2005). p values were derived from a chi2 test. akt-1 and akt-2 RNAi were also performed
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separately, and shown to have a similar effect to combined akt-1;akt-2 RNAi (data not shown).
D) GST-7::GFP is induced in response to daf-2, akt-1;akt-2, or sgk-1 RNAi. E–J) SKN-1- and
DAF-16-responsive genes that are upregulated in daf-2(e1370) L4 larvae were identified by
quantitative PCR, using actin (act-1) as a control. The level of skn-1 mRNA in these samples
was also measured (Figure S6). One representative experiment is shown, error bars represent
the SEM, and p values were derived from a Student’s t-test.
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Figure 4. skn-1 mutations suppress the longevity and stress resistance phenotypes conferred by
reduced IIS
A) skn-1 contributes to the oxidative stress resistance phenotype of daf-2(e1370) mutants. A
representative experiment is shown in which animals were exposed to 7.5 mM t-butyl hydrogen
peroxide. B) skn-1 contributes to the stress resistance phenotypes conferred by sgk-1 or
akt-1;akt-2 RNAi. Animals were scored after 5 days exposure to 150mM paraquat. Data were
combined from at least three experiments with n>90 for each group. C) Lifespan analysis of
daf-2(e1370); skn-1 mutants. D) skn-1 suppresses the longevity of daf-2(e1368) mutants. E)
In the RNAi-sensitive rrf-3 background (Simmer et al., 2002), the lifespan increase seen in
daf-2(e1368) is comparably suppressed by either skn-1 or skn-1a/c RNAi. RNAi bacteria were
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provided from the L1 stage. F, G) skn-1 mutations suppress the lifespan extension conferred
by akt-1;akt-2 or sgk-1 RNAi. Survival assays were carried out at 25°C, are from adulthood,
and represent the combined data from at least two experiments. H) skn-1 mutation does not
suppress the lifespan extension conferred by cyc-1 RNAi. The lifespan experiments in C and
D were carried out on OP50, but all others were performed on HT115 lawns. Lifespan data in
this Figure are summarized in Table 1. Unless otherwise indicated, the analyses shown were
performed at 20°C, and measured from hatching.
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Figure 5. Transgenic expression of SKN-1 extends lifespan
A) Lifespan extension in otherwise WT animals carrying the [SKN-1B/C S393A::GFP]
transgene, which expresses constitutively nuclear SKN-1C in the intestine (see text). These
independent extrachromosomal arrays were created by injecting 2.5ng/µl transgene DNA.
B) Lifespan extension in skn-1(zu67) animals carrying skn-1 transgenes. The Ex001[SKN-1B/
C::GFP], Ex008[SKN-1B/C S393A::GFP] and Ex020[SKN-1B/C S393A::GFP]
extrachromosomal arrays were originally created in WT animals by injection of 2.5, 2.5, and
10 ng/µl transgene DNA, respectively, and then bred into skn-1(zu67). The presence of the
transgene did not dramatically affect the developmental timing, brood size or age specific
fecundity of either the WT or skn-1 mutants (Figure S14). The lifespan of WT animals carrying
Ex001[SKN-1B/C::GFP] is shown for comparison. C) SKN-1C contributes to the lifespan of
skn-1(zu67) Ex001[SKN-1B/C::GFP] animals. Lifespan is reduced comparably by skn-1 and
skn-1a/c RNAi (Figure 1B). D) Presence of Ex008[SKN-1B/C S393A::GFP] increases the
lifespan of daf-16(mgDf47) mutants. E) Transgene arrays that express constitutively nuclear
SKN-1 (Ex008 or Ex020) increase skn-1(zu67) lifespan beyond WT when daf-16 is depleted
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by RNAi. Lifespan analyses were scored from hatching and performed at 20°C unless otherwise
stated, and are summarized in Table 2. The experiments in panels A and B were carried out on
OP50, and the others on HT115. Panels C and D are representative experiments, but otherwise
data were combined from at least two experiments, within which all sample sets were analyzed
in parallel. F) Cross talk among C. elegans transcriptional regulators that increase longevity
when expressed transgenically. DAF-16 physically interacts with SIR-2.1 through 14-3-3
proteins, and is required for SIR-2.1 to extend lifespan (Berdichevsky et al., 2006; Tissenbaum
and Guarente, 2001). HSF-1 and DAF-16 are predicted to bind to some of the same promoters,
and regulate some pro-longevity target genes together (Hsu et al., 2003). PHA-4 shares a
common cooperating cofactor with DAF-16 (SMK-1), extends lifespan when DAF-16 is
absent, and is required for DR to extend lifespan (Panowski et al., 2007). SKN-1 and DAF-16
are inhibited directly and in parallel by IIS (this work).
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